Research Article| Volume 43, ISSUE 4, P831-836, April 2017

Download started.


Renal angiomyolipomas: At least two diseases. A series of patients treated at two European institutions

Published:December 05, 2016DOI:



      The aim of this study is to analyze the outcome of renal angiomyolipomas (AML) at two European institutions.


      The data were collected from patients with a primary AML who were treated at Gustave Roussy, Villejuif, France and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy from 1998 to 2014. The specimens were classified as classic AML (C AML) or epithelioid AML (E AML) based on the percentage of epithelioid cells.


      There were 40 patients identified for the study (35 C AML, 5 E AML). One patient had an associated tuberous sclerosis complex. Six patients (15%) had bilateral AML. The imaging results were significantly different between C/E AML. E AML was associated with fewer bilateral lesions, more renal vein/vena cava extension, and more poor or non-fatty aspects. Surgery/active surveillance (AS)/chemo radiation were applied for 28/11/1 patients, respectively. The median tumor size was significantly smaller (3.75 cm) in patients receiving AS (median 15 cm when surgically resected). The median patient follow-up was 43 months. The three-year overall survival was significantly better for patients with C AML than E AML (100% versus 50%, p < 0.0001). The univariate analysis identified the OS prognostic factors were E AML histologic subtype (p < 0.001), poor/non fatty features (p = 0.002), and renal vein extension on imaging (p = 0.01).


      AML manifests as at least two different entities with significantly different outcomes. Epithelioid subtype, poor/non-fatty features, and renal vein involvement are all associated with worse survival.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Srigley J.R.
        • Delahunt B.
        • Eble J.N.
        • et al.
        The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia.
        Am J Surg Pathol. 2013; 37: 1469-1489
        • Thway K.
        • Fisher C.
        PEComa: morphology and genetics of a complex tumor family.
        Ann Diagn Pathol. 2015; 19: 359-368
        • Fittschen A.
        • Wendlik I.
        • Oeztuerk S.
        • et al.
        Prevalence of sporadic renal angiomyolipoma: a retrospective analysis of 61,389 in- and out-patients.
        Abdom Imaging. 2014; 39: 1009-1013
        • Venyo A.K.-G.
        A review of the literature on extrarenal retroperitoneal angiomyolipoma.
        Int J Surg Oncol. 2016; 20166347136
        • Kapoor A.
        • Girard L.
        • Lattouf J.-B.
        • et al.
        Evolving strategies in the treatment of tuberous sclerosis complex-associated angiomyolipomas (TSC-AML).
        Urology. 2016; 89: 19-26
        • He W.
        • Cheville J.C.
        • Sadow P.M.
        • et al.
        Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors.
        Mod Pathol. 2013; 26: 1355-1364
        • Martignoni G.
        • Pea M.
        • Rigaud G.
        • et al.
        Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions.
        Am J Surg Pathol. 2000; 24: 889-894
        • Lane B.R.
        • Aydin H.
        • Danforth T.L.
        • et al.
        Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid.
        J Urol. 2008; 180: 836-843
        • Jinzaki M.
        • Silverman S.G.
        • Akita H.
        • Nagashima Y.
        • Mikami S.
        • Oya M.
        Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management.
        Abdom Imaging. 2014; 39: 588-604
        • Farrell C.
        • Noyes S.L.
        • Tourojman M.
        • Lane B.R.
        Renal angiomyolipoma: preoperative identification of atypical fat-poor AML.
        Curr Urol Rep. 2015; 16: 12
        • Sung C.K.
        • Kim S.H.
        • Woo S.
        • et al.
        Angiomyolipoma with minimal fat: differentiation of morphological and enhancement features from renal cell carcinoma at CT imaging.
        Acta Radiol. 2016; 57: 1114-1122
        • Liu Y.
        • Qu F.
        • Cheng R.
        • Ye Z.
        CT-imaging features of renal epithelioid angiomyolipoma.
        World J Surg Oncol. 2015; 13: 280
        • Bissler J.J.
        • Kingswood J.C.
        Renal angiomyolipomata.
        Kidney Int. 2004; 66: 924-934
        • Flum A.S.
        • Hamoui N.
        • Said M.A.
        • et al.
        Update on the diagnosis and management of renal angiomyolipoma.
        J Urol. 2016; 195: 834-846
        • Ljungberg B.
        • Bensalah K.
        • Canfield S.
        • et al.
        EAU guidelines on renal cell carcinoma: 2014 update.
        Eur Urol. 2015; 67: 913-924
        • Bissler J.J.
        • Kingswood J.C.
        • Radzikowska E.
        • et al.
        Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
        Lancet. 2013; 381: 817-824
        • Moch H.
        • Cubilla A.L.
        • Humphrey P.A.
        • Reuter V.E.
        • Ulbright T.M.
        The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours.
        Eur Urol. 2016; 70: 93-105
        • Sobin L.H.
        • Wittekind C.
        • International Union against Cancer
        TNM classification of malignant tumours.
        6th ed. Wiley-Liss, New York2002
        • Dindo D.
        • Demartines N.
        • Clavien P.-A.
        Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
        Ann Surg. 2004; 240: 205-213
        • Kaplan E.L.
        • Meier P.
        Nonparametric estimation from incomplete observations.
        J Am Stat Assoc. 1958; 53: 457
        • Brimo F.
        • Robinson B.
        • Guo C.
        • Zhou M.
        • Latour M.
        • Epstein J.I.
        Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.
        Am J Surg Pathol. 2010; 34: 715-722
        • Seyam R.M.
        • Bissada N.K.
        • Kattan S.A.
        • et al.
        Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms.
        Urology. 2008; 72: 1077-1082
        • Bhatt J.R.
        • Richard P.O.
        • Kim N.S.
        • et al.
        Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy.
        Eur Urol. 2016; 70: 85-90
        • Kuusk T.
        • Biancari F.
        • Lane B.
        • et al.
        Treatment of renal angiomyolipoma: pooled analysis of individual patient data.
        BMC Urol. 2015; 15: 123
        • Aydin H.
        • Magi-Galluzzi C.
        • Lane B.R.
        • et al.
        Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association.
        Am J Surg Pathol. 2009; 33: 289-297
        • Nese N.
        • Martignoni G.
        • Fletcher C.D.
        • et al.
        Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification.
        Am J Surg Pathol. 2011; 35: 161-176
        • Ouzaid I.
        • Autorino R.
        • Fatica R.
        • et al.
        Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention.
        BJU Int. 2014; 114: 412-417
        • Eijkemans M.J.C.
        • van der Wal W.
        • Reijnders L.J.
        • et al.
        Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in The Netherlands.
        Am J Kidney Dis. 2015; 66: 638-645
        • Bissler J.
        • Cappell K.
        • Charles H.
        • et al.
        Long-term clinical morbidity in patients with renal angiomyolipoma associated with tuberous sclerosis complex.
        Urology. 2016; 95: 80-87